Baltimore, MD - A new meta-analysis examining the safety and efficacy of arterial closure devices (ACDs) has found varying degrees of risk associated with the use of different ACDs, compared with ...

In an analysis of the ISAR-CLOSURE trial, use of vascular closure devices was as safe and effective as manual compression for artery closure in women undergoing transfemoral angiography. Researchers ...

Evanston, IL - A new arterial suture device reduces the time to ambulation following cardiac catheterizations and may even reduce complications in PCI patients [1]. Results from the Rapid Ambulation ...

Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL™ ...

HOLLYWOOD, Fla. — While there is not yet definitive evidence that vascular closure devices produce better outcomes than manual compression, their use appears appropriate in most procedures with ...

Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below: Receive the the latest news, research, and ...

Haemonetics will shell out up to 185 million euros ($216 million) to acquire Vivasure Medical, a Galway, Ireland-based medtech that makes arterial closure devices. Boston-based Haemonetics, which is ...

VALLEY COTTAGE, New York, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Clinical use of arterial closure devices, also known as vascular closure devices, has experienced a substantial growth over the past decade ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing ...